MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,486,731 | +67.6% | 44,570 | +59.7% | 0.00% | +33.3% |
Q1 2024 | $7,450,416 | -90.5% | 27,900 | -91.8% | 0.00% | -90.0% |
Q4 2023 | $78,612,281 | +49.1% | 339,754 | -5.9% | 0.03% | +36.4% |
Q3 2023 | $52,717,081 | -38.5% | 360,977 | -2.7% | 0.02% | -37.1% |
Q2 2023 | $85,727,796 | +1395.1% | 371,116 | +1468.0% | 0.04% | +1650.0% |
Q1 2023 | $5,733,810 | -20.9% | 23,668 | -5.2% | 0.00% | -33.3% |
Q4 2022 | $7,246,962 | +567.9% | 24,968 | +49.5% | 0.00% | +200.0% |
Q3 2022 | $1,085,000 | -9.2% | 16,700 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $1,195,000 | -27.1% | 16,700 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $1,639,000 | +16.5% | 16,700 | +0.6% | 0.00% | – |
Q4 2021 | $1,407,000 | +6.2% | 16,600 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $1,325,000 | -18.1% | 16,600 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,617,000 | -16.7% | 16,600 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,942,000 | -94.8% | 16,600 | -95.1% | 0.00% | -94.4% |
Q4 2020 | $37,677,000 | -43.7% | 338,914 | -39.9% | 0.02% | -50.0% |
Q3 2020 | $66,959,000 | +14.6% | 563,962 | +9.3% | 0.04% | +5.9% |
Q2 2020 | $58,436,000 | +113.1% | 515,994 | +25.6% | 0.03% | +70.0% |
Q1 2020 | $27,423,000 | -14.4% | 410,764 | +16.8% | 0.02% | +11.1% |
Q4 2019 | $32,038,000 | +12.5% | 351,641 | +6.5% | 0.02% | 0.0% |
Q3 2019 | $28,470,000 | -17.0% | 330,197 | +0.9% | 0.02% | -14.3% |
Q2 2019 | $34,310,000 | -11.5% | 327,352 | +5.7% | 0.02% | -16.0% |
Q1 2019 | $38,781,000 | +12.4% | 309,605 | +1.1% | 0.02% | -3.8% |
Q4 2018 | $34,507,000 | -24.3% | 306,134 | +43.9% | 0.03% | -13.3% |
Q3 2018 | $45,558,000 | -7.6% | 212,760 | +20.7% | 0.03% | -11.8% |
Q2 2018 | $49,289,000 | +53.8% | 176,228 | -35.8% | 0.03% | +47.8% |
Q1 2018 | $32,042,000 | +1817.5% | 274,354 | +1407.4% | 0.02% | +2200.0% |
Q4 2017 | $1,671,000 | – | 18,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |